Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion. J of Skin [Internet]. 2019 Nov. 9 [cited 2025 Apr. 18];3:S31. Available from: https://skin.dermsquared.com/skin/article/view/758